Use of inhaled insulin in a basal/bolus insulin regimen in type 1 diabetic subjects: A 6-month, randomized, comparative trial

Diabetes Care

Volumn 28, Issue 7, 2005, Pages 1630-1635

  Skyler, Jay S ^a,i   Weinstock, Ruth S ^b,c   Raskin, Philip ^d   Yale, Jean Francois ^e   Barrett, Eugene ^f   Gerich, John E ^g   Gerstein, Hertzel C ^h  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^c SYRACUSE VA MEDICAL CENTER   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e ROYAL VICTORIA HOSPITAL   (Canada)

^f UNIVERSITY OF VIRGINIA   (United States)

^g UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^h MCMASTER UNIVERSITY   (Canada)

ⁱ UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; GLUCAGON; GLUCOSE; HEMOGLOBIN A1C; INSULIN; INSULIN ANTIBODY; ISOPHANE INSULIN;

ADOLESCENT; ADULT; AGED; ANTIGEN BINDING; ARTICLE; BLOOD GLUCOSE MONITORING; BOLUS INJECTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIET RESTRICTION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRY POWDER; FEMALE; FORCED EXPIRATORY VOLUME; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LUNG DIFFUSION CAPACITY; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; POSTPRANDIAL STATE; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; TOTAL LUNG CAPACITY;

ADMINISTRATION, INHALATION; ADOLESCENT; ADULT; AGED; BODY WEIGHT; C-PEPTIDE; CHILD; DIABETES MELLITUS, TYPE 1; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; INJECTIONS, SUBCUTANEOUS; INSULIN; MALE; MIDDLE AGED; RESPIRATORY FUNCTION TESTS;

EID: 21544464003     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.28.7.1630     Document Type: Article

References (26)

1. Reichard P, Nilsson BY, Rosenqvist U: The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 329:304-309, 1993
2. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
3. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group: Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 287:2563-2569, 2002
4. Farkas-Hirsch R (Ed.): Intensive Diabetes Management. 2nd ed. Alexandria, VA, American Diabetes Association, 1998
5. Skyler JS (Ed.): Medical Management of Type 1 Diabetes. 3rd ed. Alexandria, VA, American Diabetes Association, 1998
6. Zgibor JC, Songer TJ, Kelsey SF, Weissfeld J, Drash AL, Becker D, Orchard TJ: The association of diabetes specialist care with health care practices and glycemic control in patients with type 1 diabetes: a cross-sectional analysis from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care 23:472-476, 2000
7. Muller UA, Femerling M, Reinauer KM, Risse A, Voss M, Jorgens V, Berger M, Muhlhauser I: Intensified treatment and education of type 1 diabetes as clinical routine: a nationwide quality-circle experience in Germany. ASD (the Working Group on Structured Diabetes Therapy of the German Diabetes Association). Diabetes Care 22 (Suppl. 2):B29-B34, 1999
8. Zambanini A, Newson RB, Maisey M, Feher MD: Injection related anxiety in insulin-treated diabetes. Diabetes Res Clin Pract 46:239-246, 1999
9. Mollema ED, Snoek FJ, Heine RJ, van der Ploeg HM: Phobia of self-injecting and self-testing in insulin-treated diabetes patients: opportunities for screening. Diabet Med 18:671-674, 2001
10. Skyler JS, Cefalu WT, Kourides IA, Landschulz WH, Balagtas CC, Cheng SL, Gelfand RA: Efficacy of inhaled human insulin in type 1 diabetes mellitus: a randomised proof-of-concept study. Lancet 357:331-335, 2001
11. Gerber RA, Cappelleri JC, Kourides IA, Gelfand RA: Treatment satisfaction with inhaled insulin in patients with type 1 diabetes: a randomized controlled trial. Diabetes Care 24:1556-1559, 2001
12. Quattrin T, Belanger A, Bohannon NJ, Schwartz SL: Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes: results of a 6-month, randomized, comparative trial. Diabetes Care 27:2622-2627, 2004
13. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 21 (Suppl. 1):5-19, 1998
14. Franz MJ, Horton ES Sr, Bantle JP, Beebe CA, Brunzell JD, Coulston AM, Henry RR, Hoogwerf BJ, Stacpoole PW: Nutrition principles for the management of diabetes and related complications. Diabetes Care 17:490-518, 1994
15. American Diabetes Association: Diabetes mellitus and exercise (Position Statement). Diabetes Care 21 (Suppl. 1):40-44, 1998
16. American Diabetes Association: Standards of medical care for patients with diabetes mellitus (Position Statement). Diabetes Care 28 (Suppl. 1):S4-S36, 2005
17. Reeves M, Seigler DE, Ryan EA, Skyler JS: Glycemic control in insulin-dependent diabetes mellitus: comparison of outpatient intensified conventional therapy with continuous subcutaneous insulin infusion. Am J Med 72:673-680, 1982
18. Schade DS, Santiago JV, Skyler JS, Rizza R: intensive Insulin Therapy. Princeton, NJ, Excerpta Medica, 1983
19. Implementation of treatment protocols in the Diabetes Control and Complications Trial. Diabetes Care 18:361-376, 1995
20. Distiller LA, Robertson LI, Moore R, Bonnici F: A bolus/basal multiple injection regimen in type I diabetes: a multicentre trial using a new "fountain-pen" device for short-acting human insulin as well as long-acting human insulin. S Afr Med J 71:749-752, 1987
21. Hollander PA, Blonde L, Rowe R, Mehta AE, Milburn JL, Hershon KS, Chiasson JL, Levin SR: Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 2 diabetes: results of a 6-month, randomized, comparative trial. Diabetes Care 27: 2356-2362, 2004
22. Owens DR, Zinman B, Bolli G: Alternative routes of insulin delivery. Diabet Med 20: 886-898, 2003
23. Cherrington AD, Neal DW, Edgerton DS, Glass D, Bowen L, Hobbs CH, Leach C, Rosskamp R, Strack TR: Inhalation of insulin in dogs: assessment of insulin levels and comparison to subcutaneous injection. Diabetes 53:877-881, 2004
24. Edgerton DS, Neal DW, Scott M, Bowen L, Wilson W, Hobbs CH, Leach C, Sivakumaran S, Strack TR, Cherrington AD: Inhalation of insulin (Exubera) is associated with augmented disposal of portally infused glucose in dogs. Diabetes 54: 1164-1170, 2005
25. American Thoracic Society: Single-breath carbon monoxide diffusing capacity (transfer factor): recommendations for a standard technique. 1995 update. Am J Respir Crit Care Med 152:2185-2198, 1995
26. American Association for Respiratory Care Clinical Practice Guidelines: Single-breath carbon monoxide diffusing capacity, 1999 update. Respir Care 44:539-546, 1999